Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14
FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma [Retraction]
Received 2 December 2021
Accepted for publication 2 December 2021
Published 7 December 2021 Volume 2021:14 Pages 1601—1602
Xiao F, Zhou J. Pharmgenomics Pers Med. 2021;14:1239–1245.
At the authors request, the Editor and Publisher of Pharmacogenomics and Personalised Medicine wish to retract the published article. The authors have advised that despite the research being approved and authorized by the Ethics Committee of the School of Nursing of Chongqing Medical University, it also needed to be approved and authorized by the Ethics Committee of Chongqing Medical University. However, the authors were not aware of this requirement and failed to acquire the appropriate authorization prior to commencement of the study and have requested to retract the article.
The authors wish to apologise for this error.
Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.